Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
98.659,44
0,92%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Fusion Antibodies Plc (FAB) Fusion Antibodies Plc (FAB) Notizie

Fusion Antibodies Plc

FAB
6,70
0,15 (2,29%)
20 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
04/12/202413:18ALNCNewsFusion Antibodies receives approval of grant funding..
04/12/202412:31LSEG_RNSFusion Antibodies PLC Approval of Grant Funding Application
19/11/202414:10ALNCNewsFusion Antibodies interim loss narrows as revenue more than..
19/11/202408:00LSEG_RNSFusion Antibodies PLC Half-year Report
16/10/202414:23LSEG_RNSFusion Antibodies PLC Director/PDMR Shareholding
16/10/202408:00LSEG_RNSFusion Antibodies PLC Issue of shares to non-executive..
08/10/202414:58ALNCNewsIN BRIEF: Fusion Antibodies expects interim revenue to..
08/10/202413:32LSEG_RNSFusion Antibodies PLC Result of AGM
08/10/202408:00LSEG_RNSFusion Antibodies PLC AGM statement and trading update
02/10/202408:00LSEG_RNSFusion Antibodies PLC Block admission six monthly return
12/9/202410:54LSEG_RNSFusion Antibodies PLC Notice of AGM
09/9/202413:35LSEG_RNSFusion Antibodies PLC Director/PDMR Shareholding
09/9/202408:00LSEG_NONFusion Antibodies PLC Investor presentation
05/9/202413:15LSEG_RNSFusion Antibodies PLC Director/PDMR Shareholding
05/9/202408:00LSEG_RNSFusion Antibodies PLC Final Results
28/8/202414:52ALNCNewsFusion Antibodies expands agreement with National Cancer..
28/8/202408:00LSEG_NONFusion Antibodies PLC Expansion to OptiMAL collaboration..
22/7/202413:54LSEG_RNSFusion Antibodies PLC Director/PDMR Shareholding
18/7/202408:00LSEG_NONFusion Antibodies PLC Launch of New Interactive Investor Hub
04/7/202414:33ALNCNewsTRADING UPDATES: itim signs contract; Tekmar renews banking..
04/7/202408:00LSEG_RNSFusion Antibodies PLC Trading update
23/5/202422:08ALNCNewsTRADING UPDATES: Celadon ships to US; Oxford..
23/5/202408:00LSEG_RNSFusion Antibodies PLC New contract with existing client
02/5/202408:00LSEG_NONFusion Antibodies PLC Investor presentation
30/4/202420:54ALNCNewsEARNINGS AND TRADING: Software Circle & Beximco report..
30/4/202408:00LSEG_RNSFusion Antibodies PLC Year-end trading statement
16/4/202408:00LSEG_RNSFusion Antibodies PLC Change of auditor
15/4/202414:29ALNCNewsFusion Antibodies inks commercial contract for OptiPhage..
15/4/202408:00LSEG_RNSFusion Antibodies PLC Contract to develop a bespoke..
02/4/202415:34LSEG_RNSFusion Antibodies PLC Block admission six monthly return
28/3/202418:00LSEG_RNSFusion Antibodies PLC Total Voting Rights
11/3/202416:04LSEG_RNSFusion Antibodies PLC Holding(s) in Company
11/3/202410:10LSEG_RNSFusion Antibodies PLC Holding(s) in Company
08/3/202416:09LSEG_RNSFusion Antibodies PLC Holding(s) in Company
05/3/202411:40LSEG_RNSFusion Antibodies PLC Result of General Meeting and Total..
29/2/202418:00LSEG_RNSFusion Antibodies PLC Total Voting Rights
27/2/202415:18ALNCNewsTRADING UPDATES: Sondrel wins USD23 million contract
27/2/202408:00LSEG_RNSFusion Antibodies PLC First purchase order under MSA
14/2/202412:27ALNCNewsIN BRIEF: Fusion Antibodies raises GBP1.4 million via..
14/2/202408:15LSEG_RNSFusion Antibodies PLC Grant of options and issue of shares..
14/2/202408:00LSEG_RNSFusion Antibodies PLC Placing to raise £1,375,000
06/2/202412:48ALNCNewsFusion Antibodies strikes follow-on research and development..
06/2/202408:00LSEG_RNSFusion Antibodies PLC Follow-on project award and R&D update
01/2/202413:00ALNCNewsFusion Antibodies gets tax credit from UK HMRC for OptiMAL..
01/2/202408:00LSEG_RNSFusion Antibodies PLC HMRC R&D tax credit
Apertura: 6,55 Min: 6,55 Max: 7,10
Chiusura: 6,55

La tua Cronologia

LSE
FAB
Fusion Antibodies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network